Guest guest Posted May 11, 2007 Report Share Posted May 11, 2007 http://www.lsj.com/apps/pbcs.dll/article?AID=/20070509/ NEWS03/705090357/1001/news Published May 9, 2007 Emergent BioSolutions cuts loss (Share price drops to 10.67. Bioport somehow lost money despite more than doubling sales: investors may be learning the company is not to be trusted--Nass) W. Steele Lansing State Journal Emergent BioSolutions Inc., which operates a vaccine manufacturing facility in Lansing, today reported a first-quarter loss despite doubling its revenue. The Rockville, Md.-based company reported it lost $2.7 million, or 10 cents a share, during the first three months of the year. That's less than the $4.6 million, or 21 cents per share, it lost during the same period in 2006. Revenue was $26.4 million in the most recent quarter, up from $12.2 million one year earlier. Officials attributed the revenue boost to the delivery of 1.1 million doses of its BioThrax anthrax vaccine, which is made in Lansing, for the departments of Defense and Health and Human Services. Emergent employs about 300 people at its north Lansing facility, the former BioPort Corp. Company officials expect Emergent to post a profit for the year on revenue growth of 10 to 15 percent. Emergent, which went public last year, had revenue of $152.7 million in 2006 and posted a $22.8 million profit for the year. Contact W. Steele at 377-1015 or jwsteele@.... Copyright 2007 Lansing State Journal Use of this site signifies your agreement to the Terms of Service (updated August 2006) [back] Meryl Nass, MD Mount Desert Island Hospital Bar Harbor, Maine 04609 207 288-5081 ext. 220 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.